Wednesday, February 28, 2007 3:34:49 PM
As their own PR company will tell anyone who calls them, the next expected revenue generating project is super-EPO and that is not due for years yet.
As of today there is no personalized medicine without DnaPrint . BY ANYBODY. PERIOD. WITH DNAPRINT, PERSONALIZED MEDICINE IS AVAILABLE AND READY TO GO. WHAT DO YOU THINK MERCK WOULD PAY FOR THAT?
As of today Merck has forgotten more about personalized medicine than DNAG will ever know. They wouldn't give an already scratched off lottery ticket for it.
regards,
frog
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM